Jan 13, 2021

J&J’s one-shot Covid vaccine is safe and generates promising immune response in early trial

Posted by in category: biotech/medical

The new clinical trial data shows a single shot of the vaccine “gives sustainable antibodies,” Dr. Paul Stoffels, J&J chief scientific officer, told CNBC.

Leave a reply